Skip to main content

Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea



The Global Programme to Eliminate Lymphatic Filariasis was launched in 2000 with the goal of interrupting transmission of lymphatic filariasis (LF) through multiple rounds of mass drug administration (MDA). In Guinea, there is evidence of ongoing LF transmission, but little is known about the most densely populated parts of the country, including the capital Conakry. In order to guide the LF control and elimination efforts, serological and entomological surveys were carried out to determine whether or not LF transmission occurs in Conakry.


The prevalence of circulating filarial antigen (CFA) of Wuchereria bancrofti was assessed by an immuno-chromatography test (ICT) in people recruited from all five districts of Conakry. Mosquitoes were collected over a 1-year period, in 195 households in 15 communities. A proportion of mosquitoes were analysed for W. bancrofti, using dissection, loop-mediated isothermal amplification (LAMP) assay and conventional polymerase chain reaction (PCR).


CFA test revealed no infection in the 611 individuals examined. A total of 14,334 mosquitoes were collected; 14,135 Culex (98.6 %), 161 Anopheles (1.1 %) and a few other species. Out of 1,312 Culex spp. (9.3 %) and 51 An. gambiae (31.7 %) dissected, none was infected with any stage of the W. bancrofti parasite. However, the LAMP assay revealed that 1.8 % of An. gambiae and 0.31 % of Culex spp. were positive, while PCR determined respective prevalences of 0 % and 0.19 %.


This study revealed the presence of W. bancrofti DNA in mosquitoes, despite the apparent absence of infection in the human population. Although MDA interventions are not recommended where the prevalence of ICT is below 1 %, the entomological results are suggestive of the circulation of the parasite in the population of Conakry. Therefore, rigorous surveillance is still warranted so that LF transmission in Conakry would be identified rapidly and adequate responses being implemented.


Annual mass drug administration (MDA) with single-dose diethylcarbamazine (DEC) or ivermectin (IVM), in combination with albendazole (ALB), for 4–6 years is the global strategy for the elimination of lymphatic filariasis [1]. While it may be perceived that achieving a proper MDA coverage might be easier in urban settings in Africa where the public health system usually is stronger (in comparison to rural areas), the implementation of MDA interventions can be a challenge under certain conditions in urban settings that are characterised by overcrowded slums, intense population movements, poor definition of risk factors, low levels of transmission, uncertainty to determine local transmission, etc. [2], particularly in view of the need to achieve at least 65 % effective coverage [3].

For many years, the diagnosis of bancroftian filariasis depended exclusively on the identification of microfilariae (MF) in blood specimens taken at night [4]. Likewise, studies on the prevalence of Wuchereria bancrofti in mosquitoes have traditionally relied on manual dissection and examination [5]. Other diagnostic tests have recently been developed that include sero-diagnostic methods based on the detection of circulating filarial antigens (CFA) [6], the detection of IgG4 antibody as a marker for patent MF and the polymerase chain reaction (PCR)-based detection of W. bancrofti DNA in mosquitoes and human blood sample [7]. These advances have allowed sampling during the day for humans and high-throughput analysis for both human and vector samples, and in turn increased the sensitivity of LF diagnosis.

The neglected tropical diseases (NTDs) master plan for Guinea reported the prevalence of CFA of W. bancrofti to range between 4.5 % and 46.3 % and that of MF between 3.0 % and 16.7 % [8]. However, rural–urban migration is an important risk factor of LF transmission in endemic countries [9]. Population movements may help spread LF infection from endemic to non-endemic areas where potential LF vectors are present, or may also lead to the resurgence of infection in areas under control [10]. Interpretation of the importance of infection rates in humans is also confounded by large movements of infected individuals from endemic to non-endemic areas, especially in conflict areas in West Africa, where some transient populations or internally displaced persons or refugees from the neighbouring countries settle in large cities not directly affected by conflict [11]. Conakry, the capital of Guinea, accounts for about one quarter of the total population of the country of whom most originated from other geographical regions of the country and neighbouring Côte d’Ivoire, Liberia and Sierra Leone [11, 12].

Establishing and maintaining transmission of LF in new areas depends on the presence of appropriate vectors and their capability to sustain transmission [10]. Thus, monitoring the LF infection in populations through mosquitoes (xenomonitoring) provides an important way of demonstrating potential transmission in an area, and has been suggested as a tool for monitoring the impact of MDA on LF transmission [13, 14]. To date, while good epidemiological data on LF exist in rural areas in Guinea, there have been no reports on the status of the infection in Conakry. A mapping study carried out in Kassa, an island close to Conakry in 2005 [8], indicated no infection. However, this finding might not be representative for the city of Conakry, due to demographic, ecologic and socioeconomic differences. In view of the paucity of epidemiological data, the World Health Organization (WHO) recommended a re-mapping of LF in Conakry. Hence, the study presented here was designed to obtain baseline data on the prevalence of W. bancrofti infection, coupled with entomological surveys, in order to determine whether or not LF transmission occurs in Conakry, which would require MDA.


Ethics statement

The surveys were conducted in accordance with the study protocol approved by the Institutional Ethics Review Board of the Liverpool School of Tropical Medicine (1189RS) and from the National Ethics Committee for Research in Health (CNERS) from the Republic of Guinea (20/CNERS/12). Written informed consent was obtained from individuals aged 18 years and above. For minors (aged <18 years), written informed consent was obtained from parents or legal guardians, while minors provided oral assent. Due to high illiteracy rate, in some households, oral rather than written informed consent was obtained. CNERS explicitly approved our consent procedures.

Participants were informed about the purpose and procedures of the study, including potential risks and benefits. The data were analysed and reported to exclude any directly identifiable information, in order to maintain anonymity of participants.

Study sites

This study was carried out in Conakry, the capital of Guinea. The country is located at the coast in West Africa and shares borders with six countries: Côte d’Ivoire, Guinea Bissau, Liberia, Mali, Senegal and Sierra Leone [12]. Conakry is a peninsula of 308 km2, with a length of 34 km and a width of 1–6 km. According to a census done in 1999, the population was about 1.5 million, which is likely to have increased by more than 40 % taking into account annual growth rates. Conakry accounts for about a quarter of the total population of Guinea, and about 60 % of the urban population [15].

Detection of W. bancrofti antigen in blood

A serological survey was carried out following the WHO mapping guidelines [16] with slight modifications, as follows. First, in order to cover the entire city, sample collection sites were chosen randomly in the five districts of Conakry (Fig. 1). Second, only individuals’ aged ≥15 years from the five districts were included in the survey. We employed an immunochromatography card test (ICT) (Alere, NOW, ICT filariasis kits; Binax, Portland, USA) for the detection of circulating filarial antigen in finger-prick blood samples taken during the day. All results were read after 10 min according to the manufacturer’s instructions. Clinical examination for signs of lymphoedema was conducted for all subjects.

Fig. 1

Survey locations for collection of mosquitoes in Conakry, Guinea, between December 2012 and November 2013. Blue circle, window exit trap and pyrethrum spraying catches; red circle, window exit trap, pyrethrum spraying catches and ICT test sites

Mosquito collection

Using a map of the city, a survey of larval breeding sites was undertaken. Based on the information gathered, 15 sectors were chosen based on the potential exposure of the population to mosquito bites, according to information provided by district leaders and observation of risk factors associated to the presence of mosquito breeding sites. From this information, mosquito collection sites were selected to represent different sectors of the city (Fig. 1). This was to allow the collection of as many samples as possible. Mosquitoes were collected over a 1-year period from December 2012 to November 2013, using exit traps and pyrethrum knock-down spray sheet collections (PSC) [17] in different households. Collections were undertaken in 15 communities in all five districts of Conakry (Fig. 1). In each community, 9–10 days a month, exit traps were operated in 10 households. Exit traps and PSC were not performed in the same households. However, in case of unavailability, mosquitoes were collected in a neighbouring household. PSC collections were done once every month, between 06:00 and 09:00 h in three households.

Mosquito processing and dissection

The collected mosquitoes were identified based on their morphological characteristics [18, 19]. All dissectible female specimens of the genera of Anopheles and Culex were analysed for parity, by dissecting and inspecting the ovaries and Malpighian tubes under a microscope [20] (Table 3). Ten to 15 % of mosquitoes collected from each site were also dissected for detection of W. bancrofti larvae. The head, thorax and abdomen were dissected separately on a glass slide in three drops of saline and examined under a compound microscope for larval detection [21]. The dissected mosquitoes were scraped into individual Eppendorf tubes and all other mosquitoes were also stored individually on silica gel and sent to the Noguchi Memorial Institute for Medical Research, University of Ghana (Accra, Ghana), for subsequent molecular analyses.

Detection of W. bancrofti DNA in mosquitoes

Culex mosquitoes were grouped into pools, with a maximum of 20 mosquitoes per pool. Anopheles mosquitoes were analysed individually. DNA was extracted from the mosquitoes using the Qiagen DNeasy tissue kit (QiagenDNeasy® kit; Mississauga, Canada). Identification of parasite DNA in the mosquitoes was done using the loop-mediated isothermal amplification (LAMP) assay [22] and a PCR method [23] for detection of W. bancrofti. The LAMP assay enables the formation of a turbid solution, indicative of product amplification, and sample confirmation can therefore be done visually, or through florescent detection under UV light directly in the Eppendorf tubes. The assays were performed as described by de Souza and colleagues [22]. All LAMP-positive samples were confirmed twice and PCR analysis was conducted to confirm samples positive for the LAMP assay. A negative and positive control was included in all LAMP and PCR assays.

Statistical analysis

Data were entered onto a Microsoft Excel spreadsheet and transferred to STATA version 11 (Stata Corporation; College Station, United States of America). Pool screen version 2.0.3 [24] was used to calculate the maximum likelihood estimate of infection in the vector populations together with the associated 95 % confidence interval (CI). ArcGIS version 10.2.1 software was used for mapping the study site.


Detection of W. bancrofti prevalence

A total of 611 individuals (347 females, 56.8 %) were sampled for the detection of CFA. None (0 %) of the subjects had detectable levels of circulating parasite antigen (Table 1). However, three cases of elephantiasis of the legs were identified (two males, one female; all aged >20 years), accounting for 0.5 % of all individuals sampled.

Table 1 Prevalence of W. bancrofti infection in Conakry, Guinea between December 2012 and November 2013, as estimated by ICT

In this survey, microfilaremia was not determined since all individuals tested by ICT were negative.

Mosquito collection and dissection

Overall, 14,334 mosquitoes were collected, of which 14,135 (98.6 %) were Culex and 161 (1.1 %) were Anopheles (Table 2). Other mosquito species, specifically Mansonia uniformis and Aedes aegypti, were also collected, but at very low numbers. Overall, 13,190 (93.3 %) of female Culex and 147 (91.3 %) of female Anopheles mosquitoes were analysed for parity, by dissecting and inspecting the ovaries and Malpighian tubes under a microscope. The parity rates in Culex and Anopheles mosquitoes were 46.5 % and 38.8 %, respectively (Table 3). Results of the dissections revealed no W. bancrofti larval stages in the head, thorax or abdomen of the examined An. gambiae and Culex mosquitoes (Tables 4 and 5).

Table 2 Species composition of mosquitoes collected using window exit traps and pyrethrum spray catches (PSC)
Table 3 Distribution of mosquitoes collected from Conakry, Guinea between December 2012 and November 2013
Table 4 Wuchereria bancrofti infection rates in An. gambiae s.l. collected from Conakry, Guinea between December 2012 and November 2013
Table 5 W. bancrofti infection rates in Culex species collected from Conakry, Guinea between December 2012 and November 2013

Detection of W. bancrofti DNA in mosquitoes

Overall, 112 Anopheles mosquitoes were analysed individually, and 3,635 Culex were sorted into 184 pools with a range of 7–20 mosquitoes per pool. Of the mosquitoes processed, 2 (1.8 %) An. gambiae and 11 pools of Culex were found positive (Tables 4 and 5), when subjected to a LAMP assay. The pool screening calculation indicated a maximum likelihood estimate (MLE) of infection of 0.31 % (95 % CI: 0.15–0.57 %) for Culex. All LAMP-positive samples were further analysed using PCR. The two LAMP-positive An. gambiae samples were negative by PCR. Seven of the 11 Culex pools positive by LAMP were also positive by PCR. The pool screening calculation indicated a MLE of 0.20 % (95 % CI: 0.07–0.41 %).


A cross-sectional ICT antigen detection survey carried out in all five districts of the capital city of Guinea revealed that none of the 611 individuals aged ≥15 years had detectable levels of CFA. This is in accordance with the result of a study performed in 2005 at Kassa, an island community of Conakry [8], which also reported a zero prevalence using the same diagnostic approach. Based on these results and WHO recommendations to treat only those endemic areas where the prevalence is above 1 %, the city of Conakry does not qualify for MDA.

To demonstrate the potential for active transmission in this urban environment, An. gambiae and Culex mosquitoes were collected and processed for detection of W. bancrofti infection, using standard dissections, followed by more sophisticated molecular methods. Importantly, none of the dissected mosquitoes was found positive. However, some mosquitoes further processed by molecular tests were found positive. Arguments have been made against dissection as opposed to molecular methods for monitoring transmission. A major constraint of dissections is the difficulty to detect MF and third-stage larvae (L3) [14, 25] and the large numbers of mosquitoes that need to be processed to find infections in areas with low endemicity [14, 26]. Thus, there has been an increased interest in molecular-based detection methods that can either use individual mosquitoes or pools, resulting in rapid, high-throughput screening of mosquito vectors [26, 27]. Our study confirms that molecular methods are more sensitive than standard dissection for the detection of infections in mosquito vectors [28].

Very low numbers of An. gambiae were collected in this study. While this might bring into question the effectiveness of the collection method, it is important to note that 12 monthly collections were undertaken and the same methods were used for the collection of both Anopheles and Culex mosquitoes. Mosquitoes were collected by two different methods, namely window exit traps and PSC [17]. The latter has been widely used in sampling Anopheles mosquitoes in malaria intervention programmes [29] and remains the ‘gold’ standard for collecting indoor-resting, blood-fed and gravid mosquitoes [29, 30]. In West African cities and urban areas with high pollution levels, Culex mosquitoes are the predominant mosquito species [22, 31]. Likewise, the use of the same collection methods in rural areas reveals higher proportions of Anopheles compared to Culex [32]. As such, the low numbers of An. gambiae collected in this study cannot be attributed to the collection method, but rather to the vector ecology. A survey of the breeding sites in Conakry revealed these to be heavily polluted and presenting ideal conditions for the breeding of Culex, compared to Anopheles, which prefer clean breeding sources.

The results from the LAMP and PCR assays may suggest that the LAMP has higher sensitivity as an epidemiological tool for detecting W. bancrofti infection compared to PCR, although previous reports have shown them to be substantially similar [33]. The LAMP uses four primers (six distinct sequences) that are simultaneously used to initiate DNA synthesis from the original unamplified DNA to generate a stem-loop DNA for subsequent LAMP cycling. Thus, target selectivity is higher than in conventional PCR [34, 35]. In addition to high sensitivity, the LAMP is also less prone to the presence of irrelevant DNA and inhibition compared to PCR and has the advantage of shorter reaction time, simple readout system and the use of cheaper technology tools [3436]. As such, it enjoys increasing popularity for the diagnosis of a host of diseases [22, 37, 38]. Indeed, LAMP represents a powerful tool that can be employed in the evaluation of LF control activities, especially in the end-game when interruption of LF transmission must be certified. However, the epidemiological usefulness of the LAMP assay must be determined in carefully thought out studies, with sufficiently high numbers of vector mosquitoes.

Various studies conducted in different localities in West Africa have identified An. gambiae as the main LF vector species [3941]. However, in our collections, the proportion of An. gambiae among all the mosquitoes caught was low, and hence, the infection rate must be interpreted with caution. Indeed, very high numbers of mosquitoes should be analysed in settings characterised by low levels of infection in the human population, so that very low levels of infection in the vectors can be determined [42]. Moreover, for parasitic diseases and more specifically LF whose infection is related to the parasite load and thus the frequency of infective bites [43], infection in an urban system characterised by a low vector density may not lead to the transmission of W. bancrofti. Nonetheless, given that LAMP identified two An. gambiae mosquitoes in Conakry as positive, is it not possible to rule out transmission without further detailed entomological and parasitological studies, which calls for continuous, rigorous surveillance.

While Culex mosquitoes might not play a role in LF transmission in West Africa [22, 40, 44], our results suggest that Culex mosquitoes are capable of ingesting parasite material while feeding on MF-positive individuals, demonstrating the potential of using non-vector species as a proxy for determining the presence of LF in human populations. Fischer and colleagues [45] showed in laboratory experiments that parasite DNA can be detected in both vector and non-vector mosquitoes for 2 weeks or longer after they ingest MF-positive blood. Thus, the detection of W. bancrofti DNA in mosquitoes confirms that infected individuals are present in Conakry. This indicates that transmission from mosquitoes to humans may occur, albeit at very low levels. Outbreaks of Culex mosquitoes in urban cities in West Africa have coincided with the development of large cities, which has taken an extraordinary expansion in recent decades [9, 46, 47]. Interestingly, in 1981, Fain reported that in West African regions, local strains of W. bancrofti have not yet fully adapted to Culex mosquitoes to facilitate transmission [48], but this claim requires further scientific inquiry.

We were unable to demonstrate ongoing transmission of LF based on infection rates in humans and mosquitoes. Nevertheless, the presence of two infected An. gambiae vectors using a diagnostic method that is not stage-specific implies that people may be at risk of infection [23]. However, the prevalence of parasite DNA in mosquitoes does not necessarily imply that LF transmission is ongoing in a given setting [14]. Studies by Farid and colleagues showed that mosquitoes that fed on people with very low levels of MF sometimes ingested MF but rarely produced infective larvae [49]. However, to ascertain the transmission of LF in areas where positive mosquitoes were detected, we recommend the use of gravid traps for the collection of mosquitoes [50], followed by stage-specific molecular detection methods for W. bancrofti [51]. This study further points to the focal nature of LF transmission, and the usefulness of xenomonitoring. As shown in the present investigation, analysing 611 individuals out of a population of over 1.5 million inhabitants (based on logistical, programmatic and ethical considerations) may be grossly inadequate to determine the presence of infection in areas with low infection levels in the population. As such, the widely used methodology in assessing the transmission of LF in areas with low infection rates requires critical review.


Our study demonstrated the presence of W. bancrofti DNA in mosquitoes in Conakry, despite the apparent absence of circulating filarial antigen in the human population. The study also demonstrated the utility of the LAMP assay in xenomonitoring. Based on the findings reported here and on WHO recommendations to undertake MDA in implementation units with prevalence of 1 % or more, the city of Conakry does not qualify for MDA. However, rigorous surveillance through testing of a much larger human population sample size and entomological surveys, is required to monitor the epidemiological situation of LF in Conakry as well as inform future decisions.


  1. 1.

    Kwansa-Bentum B, Aboagye-Antwi F, Otchere J, Wilson MD, Boakye DA. Implications of low-density microfilariae carriers in Anopheles transmission areas: molecular forms of Anopheles gambiae and Anopheles funestus populations in perspective. Parasit Vectors. 2014;7:157.

    PubMed Central  Article  PubMed  Google Scholar 

  2. 2.

    Simonsen PE, Mwakitalu ME. Urban lymphatic filariasis. Parasitol Res. 2013;112:35–44.

    PubMed Central  Article  PubMed  Google Scholar 

  3. 3.

    Ramaiah KDDP, Appavoo NC, Ramu K, Augustin DJ, Kumar KN, et al. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health. 2000;5:842–47.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    McMahon JE, Marshall TF, Vaughan JP, Abaru DE. Bancroftian filariasis: a comparison of microfilariae counting techniques using counting chamber, standard slide and membrane (nuclepore) filtration. Ann Trop Med Parasitol. 1979;73:(5)457–64.

    CAS  PubMed  Google Scholar 

  5. 5.

    Cartel JL, Nguyen NL, Spiegel A, Moulia-Pelat JP, Plichart R, Martin PMV, et al. Wuchereria bancrofti infection in human and mosquito populations of a Polynesian village ten years after interruption of mass chemoprophylaxis with diethylcarbamazine. Trans R Soc Trop Med Hyg. 1992;86:414–6.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Weil GJ, Pani SP. Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India. Trop Med Int Health. 2000;5:359–63.

    Article  Google Scholar 

  7. 7.

    Farid HA, Hammad RE, Hassan MM, Morsy ZS, Kamal IH, Weil GJ, et al. Detection of Wuchereria bancrofti in mosquitoes by the polymerase chain reaction: a potentially useful tool for large-scale control programmes. Trans R Soc Trop Med Hyg. 2001;95(1):29–32.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Anonymous. Plan directeur (master plan) incluant le rapport sur la cartographie de la filariose lymphatique en Guinée. Programme National de Lutte contre l’Ochocercose et les Maladies Tropicales Négligées. Ministère de la Santé et de l’Hygiène Publique 2013;77.

  9. 9.

    Alirol E, Getaz L, Stoll B, Chappuis F, Loutan L. Urbanisation and infectious diseases in a globalized world. Lancet Infec Dis. 2011;11:131–41.

    Article  Google Scholar 

  10. 10.

    Ramaiah KD, Edwin M. Population migration: implications for lymphatic filariasis elimination programmes. PLoS Negl Trop Dis. 2013;7(3):e2079.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  11. 11.

    UNHCR. 2015 UNHCR subregional operations profile - West Africa.

  12. 12.

    Karam M, Goepogui A, Midiaou MB. Analyse de la situation des maladies tropicales négligées en Guinée. Ministère de la Santé et de l’Hygiène Publique. 2010;51.

  13. 13.

    Chambers EW, Shannon K, McClintock MF, Avery JD, King MH, Bradley MA, et al. Xenomonitoring of Wuchereria bancrofti and Dirofilaria immitis infections in mosquitoes from American Samoa. Trapping considerations and a comparison of polymerase chain reaction assays with dissection. Am J Trop Med Hyg. 2009;80(5):774–81.

    PubMed  Google Scholar 

  14. 14.

    Farid HA, Morsy ZS, Helmy H, Ramzy RM, Setouhy ME, Weil JG. A critical appraisal of molecular xenomonitoring as a tool for assessing progress toward elimination of lymphatic filariasis. Am J Trop Med Hyg. 2007;77(4):593–600.

    PubMed Central  PubMed  Google Scholar 

  15. 15.

    Calvertoń Maryland USA. Enquête démographique et de santé Guinée. Direction Nationale de la Statistique, Ministère du Plan et la Coopération, Conakry. Guinée Macro International Inc 2000;370.

  16. 16.

    WHO. Operational guidelines for rapid mapping of bancroftian filariasis in Africa. Geneva: World Health Organization; 2000.

    Google Scholar 

  17. 17.

    WHO. Global Programme to eliminate lymphatic filariasis: practical entomology. Geneva: World Health Org; 2013.

  18. 18.

    Gillies MT, De Meillon B. The Anophelinae of Africa South of the Sahara (Ethiopian Zoographical Region). South African Institute of Medical Research Johannesburg. 1968;54:343.

    Google Scholar 

  19. 19.

    Harbach R: The mosquitoes of the subgenus Culex in the Southwester Asia and Egypt (Diüptera: Culicidae). Contrib Amer Ent Inst. 1988;24(1):240.

  20. 20.

    Shriram AN, Krishnamoorthy K, Sehgal SC. Transmission dynamics of diurnally subperiodic lymphatic filariasis transmitted by Ochlerotatus (Finlaya) niveus in the Andaman and Nicobar Islands. Indian J Med Res. 2008;127:37-43.

  21. 21.

    Boakye DA, Wilson MD, Appawu MA, Gyapong J. Vector competence, for Wuchereria bancrofti, of the Anopheles populations in the Bongo district of Ghana. Ann Trop Med Parasitol. 2004;98:501–8.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    de Souza DK, Sesay S, Moore MG, Ansumana R, Narh CA, Kollie K, et al. No evidence for lymphatic filariasis transmission in big cities affected by conflict related rural–urban migration in Sierra Leone and Liberia. PLoS Negl Trop Dis. 2014;8(2):e2700.

    PubMed Central  Article  PubMed  Google Scholar 

  23. 23.

    Ramzy RMR, Farid HA, Kamal IH, Ibrahim GH, Morsy ZS, Faris R, et al. A polymerase chain reaction-based assay for detection of Wuchereria bancrofti in human blood and Culex pipiens. Trans R Soc Trop Med Hyg. 1997;91:156–60.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Katholi CR, Unnasch TR. Important experimental parameters for determining infection rates in arthropod vectors using pool screening approaches. Am J Trop Med Hyg. 2006;74(5):779–785.

    PubMed  Google Scholar 

  25. 25.

    Pedersen EM, Stolk WA, Laney SJ, Michael E. The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic Filariasis. Trends Parasitol. 2009;25(7):319–27.

    Article  PubMed  Google Scholar 

  26. 26.

    Boakye DA, Baidoo HA, Glah E, Brown C, Appawu M, Wilson MD. Monitoring lymphatic filariasis interventions: adult mosquito sampling, and improved PCR–based pool screening method for Wuchereria bancrofti infection in Anopheles mosquitoes. Filaria J. 2007;6:13.

    PubMed Central  Article  PubMed  Google Scholar 

  27. 27.

    Bockarie MJ. Molecular xenomonitoring of lymphatic filariasis. Center for Global Health and Diseases, Case Western Reserve University, School of medicine, Cleveland, Ohio. Am J Trop Med Hyg. 2007;77(74):591–2.

    PubMed  Google Scholar 

  28. 28.

    Plichart C, Sechan Y, Davies N, Legrand A-M. PCR and dissection as tools to monitor filarial infection of Aedes polynesiensis mosquitoes in French Polynesia. Filaria J. 2006;5:2.

    PubMed Central  Article  PubMed  Google Scholar 

  29. 29.

    Onyango S, Kitron U, Mungai P, Muchiri EM, Kokwaro E, King CH, et al. Monitoring malaria vector control interventions: effectiveness of five different adult mosquito sampling methods. J Med Entomol. 2013;50(5):1140–51.

    PubMed Central  Article  PubMed  Google Scholar 

  30. 30.

    Mboera LE. Sampling techniques for adult afrotropical malaria vectors and their reliability in the estimation of entomological inoculation rate. Tanzan Health Res Bull. 2005;7(3):117–24.

    CAS  PubMed  Google Scholar 

  31. 31.

    de Souza DK, Koudou BG, Bolay FK, Boakye DA, Bockarie MJ. Filling the gap 115 years after Ronald Ross. The distribution of the Anopheles coluzzii and Anopheles gambiae s.s from Freetown and Monrovia, West Africa. PLos One. 2013;8(5):e64939.

    PubMed Central  Article  PubMed  Google Scholar 

  32. 32.

    Mwangangi JM, Midega J, Kahindi S, Njoroge L, Nzovu J, Githure J, et al. Mosquito species abundance and diversity in Malindi, Kenya and their potential implication in pathogen transmission. Parasitol Res. 2012;110:61–71.

    Article  PubMed  Google Scholar 

  33. 33.

    Takagi H, Itoh M, Kasai S, Yahathugoda TC, Weerasooriya MV, Kimura E. Development of loop-mediated isothermal amplification method for detecting Wuchereria bancrofti DNA in human blood and vector mosquitoes. Int J Parasitol. 2011;60:493–7.

    CAS  Article  Google Scholar 

  34. 34.

    Notomi T, Hiroto O, Harumi M, Toshihiro Y, Keiko W, Nobuyuki A, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28:E63.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  35. 35.

    Takagi H, Itoh M, Islam MZ, Razzaque A, Ekram AR, Hashighuchi Y. Sensitive, specific, and rapid detection of Leishmania donovani DNA by loop-mediated isothermal amplification. Am J Trop Med Hyg. 2009;81(4):578–82.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Adams ER, Schoone GJ, Ageed AF, Safi SE, Henk DFH. Development of a reverse transcriptase loop-mediated isothermal amplification (LAMP) assay for the sensitive detection of Leishmania parasites in clinical samples. Am J Trop Med Hyg. 2010;82:591–6.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  37. 37.

    Aydin-Schmidt B, Xu WP, Gonzalez IJ, Polley SD, Bell D, Shakely D, et al. Loop-mediated isothermal amplification (LAMP) accurately detects malaria DNA from filter paper blood samples of low density parasitaemias. PLos One. 2014;9(8):e103905.

    PubMed Central  Article  PubMed  Google Scholar 

  38. 38.

    Kaewphinit T, Arunrut N, Kiatpathomchai W, Santiwatanakul S, Jaratsing P, Chansiri K. Detection of Mycobacterium tuberculosis by using loop-mediated isothermal amplification combined with a lateral flow dipstick in clinical samples. Biomed Res Int. 2013;10:926230–6.

    Google Scholar 

  39. 39.

    Coulibaly YI, Dembele B, Diallo AA, Kristensen S, Konate S, Traore FS. Wuchereria bancrofti transmission pattern in southern Mali prior to and following the institution of mass drug administration. Parasite Vectors. 2013;6:247.

    Article  Google Scholar 

  40. 40.

    Gbakima AA, Appawu MA, Dadzie S, Karikari C, Sackey SO, Wilmot AB, et al. Lymphatic filariasis in Ghana: establishing the potential for an urban cycle of transmission. Trop Med Int Health. 2005;4:387–92.

    Article  Google Scholar 

  41. 41.

    Richards FO, Eigege A, Miri ES, Kal A, Umaru J. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria. PLoS Negl Trop Dis. 2011;5(10):e1346.

    PubMed Central  Article  PubMed  Google Scholar 

  42. 42.

    Burkot T, Kazuyo I. The PacELF programme: will mass drug administration be enough? Trends Parasitol. 2002;18(7):109–15.

    Article  PubMed  Google Scholar 

  43. 43.

    Southgate BA. Recent advances in the epidemiology and control of filarial infections including entomological aspects of transmission. Trans R Soc Trop Med Hyg. 1984;78:19–27.

    Article  PubMed  Google Scholar 

  44. 44.

    Appawu MA, Dadzie SK, Baffoe-Wilmot A, Wilson MD. Lymphatic filariasis in Ghana: entomological investigation of transmission dynamics and intensity in communities served by irrigation systems in the upper east of Ghana. Trop Med Int Health. 2001;6:511–6.

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    Fischer P, Erickson SM, Fischer K, Fuchs JF, Rao RU, Christensen BM, et al. Persistence of Brugia malayi DNA in vector and non-vector mosquitoes: implications for xenomonitoring and transmission monitoring of lymphatic filariasis. Am J Trop Med Hyg. 2007;76:502–7.

    PubMed Central  CAS  PubMed  Google Scholar 

  46. 46.

    Castro MC, Kanamori S, Kannady K, Mkude S, Killeen GF, Fillinger U. The importance of drains for the larval development of lymphatic filariasis and malaria vectors in Dar es Salaam, United Republic of Tanzania. PLoS Negl Trop Dis. 2010;4:e693.

    PubMed Central  Article  PubMed  Google Scholar 

  47. 47.

    Leon DA. Cities, urbanization and health. Int J Epidemiol. 2008;37:4–8.

    Article  PubMed  Google Scholar 

  48. 48.

    Fain A. Pourquoi faut-il éliminer les filarioses? Institut de Médécine Tropicale Prince. Ann Soc Belge Med Trop. 1981;61:145–54.

    CAS  Google Scholar 

  49. 49.

    Farid HA, Kamal SA, Weil GJ, Adham FK, Ramzy RMR. Filariasis elimination in Egypt: impact of low microfilaraemics as sources of infection for mosquitoes. East Mediterr Health J. 2003;9:863–72.

    CAS  PubMed  Google Scholar 

  50. 50.

    Harris C, Kihonda J, Lwetoijera D, Dongus S, Devine G, Majambere S. A simple and efficient tool for trapping gravid Anopheles at breeding sites. Parasit Vectors. 2011;4:125.

    PubMed Central  Article  PubMed  Google Scholar 

  51. 51.

    Laney SJ, Ramzy RMR, Helmy HH, Farid HA, Ashour AA, Weil GJ, et al. A detection of Wuchereria bancrofti L3 larvae in mosquitoes. A reverse transcriptase PCR assay evaluating infection and infectivity. PLoS Negl Trop Dis. 2010;4:e602.

    PubMed Central  Article  PubMed  Google Scholar 

Download references


We would like to address special thanks to the National Programme for Onchocerciasis, Blindness and Neglected Tropical Diseases (Conakry-Guinea). We are grateful to Dr. Oumar B Barry and the laboratory technicians (Arsène Sagno, Marie-Louise Niamy, Koné Raymond, Kéloi Jean, Kéita Mamy, Séssé Luc, Algassimou Bah, Barry A Oumar and Guoepogui Maoro) for their contribution to mosquito collection and dissection. Helen Keller International (HKI) Guinea provided logistic support. We thank the parasitology staff of the Noguchi Memorial Institute for Medical Research (Dr. Irene Ayi and Prof. Maxwell Appawu) for arranging the processing of mosquito samples in their institute. We acknowledge the cooperation of the communities of Conakry for smooth implementation of field activities. This study was supported by the Filarial Programs Support Unit from Liverpool School of Tropical Medicine, through funds from the DFID.

Author information



Corresponding author

Correspondence to Benjamin G. Koudou.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Conceived and designed the experiments: AG, MJB and BGK. Supervised the implementation of field works: AG and BGK. Performed the experiments: BLK BSM and LD. Analysed the data: BLK, DKdS and BGK. Processed mosquito samples: BLK, DKdS, CAN and SAK. Wrote the first draft of the manuscript: BLK DKdS and BGK. Revised the manuscript: SKD, DAB, JU, MJB and BGK. Provided conceptual advice and final editorial feedback prior to manuscript submission: JU, MJB and BGK. All authors read and approved the final version of the manuscript.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kouassi, B.L., de Souza, D.K., Goepogui, A. et al. Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea. Parasites Vectors 8, 492 (2015).

Download citation


  • Guinea
  • Lymphatic filariasis
  • Mass drug administration
  • Transmission
  • Wuchereria bancrofti